APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autism Spectrum Disorder Diagnosis and Therapeutics

Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.

Selected research

Market Analysis & Forecast

Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchAutism Spectrum Disorder Diagnosis and Therapeutics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Autism Spectrum Disorder Diagnosis and Therapeutics Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Autism Spectrum Disorder Diagnosis and Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autism Spectrum Disorder Diagnosis and Therapeutics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Autism Spectrum Disorder Diagnosis and Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.

Global Autism Spectrum Disorder Diagnosis and Therapeutics key players include Otsuka, AstraZeneca, Pfizer, etc. Global top three manufacturers hold a share about 10%.

Europe is the largest market, with a share about 30%, followed by United States and China, both have a share about 45 percent.

Read the full market overview

In terms of product, Autistic Disorder is the largest segment, with a share about 35%. And in terms of application, the largest application is Children and Teenagers, followed by Adults.

Report Includes

This report presents an overview of global market for Autism Spectrum Disorder Diagnosis and Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Autism Spectrum Disorder Diagnosis and Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Autism Spectrum Disorder Diagnosis and Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Autism Spectrum Disorder Diagnosis and Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Autism Spectrum Disorder Diagnosis and Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Autism Spectrum Disorder Diagnosis and Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Company

Otsuka

AstraZeneca

Pfizer

Eli Lilly

Johnson & Johnson

Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Type

Autistic Disorder

Asperger Syndrome

Childhood Disintegrative Disorder

Others

Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Application

Children and Teenagers

Adults

Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder Diagnosis and Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder Diagnosis and Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder Diagnosis and Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Autism Spectrum Disorder Diagnosis and Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Autism Spectrum Disorder Diagnosis and Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autism Spectrum Disorder Diagnosis and Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Autistic Disorder Major Player Table 3. Asperger Syndrome Major Player Table 4. Childhood Disintegrative Disorder Major Player Table 5. Others Major Player Table 6. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Children and Teenagers Major Player Table 8. Adults Major Player Table 9. Autism Spectrum Disorder Diagnosis and Therapeutics Industry Trends Table 10. Autism Spectrum Disorder Diagnosis and Therapeutics Industry Drivers Table 11. Autism Spectrum Disorder Diagnosis and Therapeutics Industry Opportunities and Challenges Table 12. Autism Spectrum Disorder Diagnosis and Therapeutics Industry Restraints Table 13. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Share by Region (2021-2026) Table 16. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Share by Region (2027-2032) Table 18. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Players (2021-2026) Table 20. Global Autism Spectrum Disorder Diagnosis and Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Autism Spectrum Disorder Diagnosis and Therapeutics Key Players Headquarters & Area Served Table 22. Global Autism Spectrum Disorder Diagnosis and Therapeutics Players, Product Type & Application Table 23. Global Autism Spectrum Disorder Diagnosis and Therapeutics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Autism Spectrum Disorder Diagnosis and Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Otsuka Company Information Table 37. Otsuka Business Overview Table 38. Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio Table 40. Otsuka Recent Development Table 41. AstraZeneca Company Information Table 42. AstraZeneca Business Overview Table 43. AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio Table 45. AstraZeneca Recent Development Table 46. Pfizer Company Information Table 47. Pfizer Business Overview Table 48. Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio Table 50. Pfizer Recent Development Table 51. Eli Lilly Company Information Table 52. Eli Lilly Business Overview Table 53. Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio Table 55. Eli Lilly Recent Development Table 56. Johnson & Johnson Company Information Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio Table 60. Johnson & Johnson Recent Development Table 61. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 64. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 65. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 67. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 68. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 69. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 70. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 71. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 72. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 74. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 75. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 76. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 77. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 78. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 79. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 80. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 81. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 82. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 83. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 85. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 86. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 87. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 88. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 89. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 90. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 92. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Autism Spectrum Disorder Diagnosis and Therapeutics Image Figure 2. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Autistic Disorder Image Figure 5. Asperger Syndrome Image Figure 6. Childhood Disintegrative Disorder Image Figure 7. Others Image Figure 8. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Children and Teenagers Image Figure 11. Adults Image Figure 12. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (US$ Million) & (2021-2032) Figure 13. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Autism Spectrum Disorder Diagnosis and Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032) Figure 25. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032) Figure 26. North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Country (2021-2032) Figure 27. United States Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032) Figure 32. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032) Figure 33. Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Country (2021-2032) Figure 34. Germany Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032) Figure 44. China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032) Figure 45. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032) Figure 47. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Region (2021-2032) Figure 49. Japan Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032) Figure 57. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032) Figure 58. SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Country (2021-2032) Figure 59. Brazil Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Autism Spectrum Disorder Diagnosis and Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Autistic Disorder
  • Asperger Syndrome
  • Childhood Disintegrative Disorder
  • Others
Applications
  • Children and Teenagers
  • Adults
Companies covered
  • Otsuka
  • AstraZeneca
  • Pfizer
  • Eli Lilly
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Autism Spectrum Disorder Diagnosis and Therapeutics Market by Type
  3. 1.2.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Autistic Disorder
  5. 1.2.3 Asperger Syndrome
  6. 1.2.4 Childhood Disintegrative Disorder
  7. 1.2.5 Others
  8. 1.3 Autism Spectrum Disorder Diagnosis and Therapeutics Market by Application
  9. 1.3.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Children and Teenagers
  11. 1.3.3 Adults
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Autism Spectrum Disorder Diagnosis and Therapeutics Market Dynamics
  1. 2.1 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Trends
  2. 2.2 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Drivers
  3. 2.3 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Opportunities and Challenges
  4. 2.4 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Growth Trends by Region
  3. 3.2.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Players
  2. 4.1.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Autism Spectrum Disorder Diagnosis and Therapeutics Players, Product Type & Application
  8. 4.5 Global Autism Spectrum Disorder Diagnosis and Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Autism Spectrum Disorder Diagnosis and Therapeutics Tier 1, Tier 2, and Tier 3
5 Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Type
  1. 5.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Type (2021-2032)
6 Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Application
  1. 6.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Otsuka
  2. 7.1.1 Otsuka Company Information
  3. 7.1.2 Otsuka Business Overview
  4. 7.1.3 Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
  6. 7.1.5 Otsuka Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Eli Lilly
  20. 7.4.1 Eli Lilly Company Information
  21. 7.4.2 Eli Lilly Business Overview
  22. 7.4.3 Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
  24. 7.4.5 Eli Lilly Recent Developments
  25. 7.5 Johnson & Johnson
  26. 7.5.1 Johnson & Johnson Company Information
  27. 7.5.2 Johnson & Johnson Business Overview
  28. 7.5.3 Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
  30. 7.5.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue (2021-2032)
  2. 8.2 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country
  11. 8.6.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country
  11. 9.6.1 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue (2021-2032)
  2. 10.2 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country
  11. 11.6.1 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Autism Spectrum Disorder Diagnosis and Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst